Advisory Opinion regarding certain drug delivery device patents submitted for listing in the Orange Book under Section 505 of the Federal Food, Drug, and Cosmetic Act

 
Docket ID: FDA-2011-A-0363
Agency: Food and Drug Administration (FDA)
Parent Agency: Department of Health and Human Services (HHS)
Docket Details open glossary dialog  
Related RINs: None
Related Dockets: None
Short Title: Advisory Opinion regarding certain drug delivery device patents submitted for listing in the Orange Book under Section 505 of the Federal Food, Drug, and Cosmetic Act
Keyword(s): Section 505, certain drug delivery, patents, Advisory Opinion, FFDCA, CDER, open
Type: Nonrulemaking
Docket Status: OPEN
Center: CDER
Docket Item Code: A
 

Primary Documents

View All  (3)

Supporting Documents

View All  (5)
Comments Not Accepted
Supporting & Related Material
Posted: 07/20/2011
ID: FDA-2011-A-0363-0002
Comments Not Accepted
Supporting & Related Material
Posted: 07/20/2011
ID: FDA-2011-A-0363-0003
Comments Not Accepted
Supporting & Related Material
Posted: 07/20/2011
ID: FDA-2011-A-0363-0006

Comments

 
No comments posted.

0
Comments Received*
*This count refers to the total comment/submissions received on this docket, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.